U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753356) titled 'VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY' on Aug. 04.
Brief Summary: This study aims to prospectively validate the Fusion CEMEP score to assess the safety and efficacy of omitting systematic prostate biopsy in patients undergoing multiparametric magnetic resonance imaging-targeted biopsy. The main objective is to determine if target-only biopsy guided by the score is sufficient for clinically significant prostate cancer detection while reducing overtreatment and unnecessary cores.
Study Start Date: Aug. 15
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer
Prostatic Neoplasms/Diagnosis
Intervent...